ACCP: Accelerated Pharma, Inc. - Summary | Jitta

Accelerated Pharma, Inc.

NASDAQ:ACCP

Notice
Stock data is unavailable or the company’s delisted.
Price
n/a
Loss Chance
58.4%
0.08JITTA SCORE
n/a
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (15)
Financial Strength (0)
Return to Shareholders (10)
Competitive Advantage (0)
Jitta Signs
Recent Business PerformanceEarning decline 5.91% in the last year
Key Stats
Jitta Score
Jitta Line
0.07
n/a
2.21
147.57%
COMPANY DESCRIPTION
Accelerated Pharma, Inc., a clinical stage pharmaceutical company, focuses on the development of pharmaceutical products for the treatment of various cancer indications. Its lead product candidate is Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications. Accelerated Pharma, Inc. was founded in 2014 and is based in Westport, Connecticut.